West Pharmaceutical Services Inc. buy KeyCorp
Start price
28.07.23
/
50%
€331.80
Target price
28.07.24
€349.62
Performance (%)
-19.98%
End price
29.07.24
€265.50
Summary
This prediction ended on 29.07.24 with a price of €265.50. The prediction for West Pharmaceutical Services Inc. disappointed with a performance of -19.98%. KeyCorp has a follow-up prediction for West Pharmaceutical Services Inc. where he still thinks West Pharmaceutical Services Inc. is a Buy. Dividends of €0.56 are taken into consideration when calculating the performance. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| West Pharmaceutical Services Inc. | 3.019% | 3.019% | -16.570% |
| iShares Core DAX® | -0.060% | 1.544% | 23.246% |
| iShares Nasdaq 100 | 4.850% | 7.081% | 18.615% |
| iShares Nikkei 225® | 3.504% | 10.943% | 22.389% |
| iShares S&P 500 | 2.820% | 4.547% | 11.057% |
Comments by KeyCorp for this prediction
In the thread West Pharmaceutical Services Inc. diskutieren
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at KeyCorp from $375.00 to $385.00. They now have an "overweight" rating on the stock.
Ratings data for WST provided by MarketBeat
In the thread Trading West Pharmaceutical Services Inc.
Die von KeyCorp gewählte maximale Laufzeit wurde überschritten
Current prediction by KeyCorp for West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€208.10
14.02.25
14.02.25
€309.24
14.02.26
14.02.26
18.07%
29.10.25
29.10.25
Stopped prediction by KeyCorp for West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€264.30
24.10.25
24.10.25
€301.42
24.10.26
24.10.26
-7.04%
29.10.25
29.10.25
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€373.10
13.02.24
13.02.24
€438.98
13.02.25
13.02.25
-46.94%
14.02.25
14.02.25